Home › NDC Lookup › RxCUI directory › RxCUI 1805011

2 ML bendamustine hydrochloride 90 MG/ML Injection — RxCUI 1805011

Name: 2 ML bendamustine hydrochloride 90 MG/ML Injection (RxCUI 1805011)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1805011 Semantic clinical drug · SCD Retired or remapped concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1805011

Official name2 ML bendamustine hydrochloride 90 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusRetired or remapped concept

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)51 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web

No related-concept groups were available for this RxCUI in the loaded RxNorm data. That does not prove that no related concepts exist.

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1805011 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
63459-0390-08	1 VIAL, SINGLE-DOSE in 1 CARTON (63459-390-08) / 5 mL in 1...	TREANDA	Cephalon, LLC	2010-01-05
63459-0391-20	1 VIAL, SINGLE-DOSE in 1 CARTON (63459-391-20) / 20 mL in 1...	TREANDA	Cephalon, LLC	2008-03-31

Observed labelers: Cephalon, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9033	Inj, bendamustine hcl, 1mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.